INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

82,042 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale · 10b5-1 plan
SELL$88K
1,034 sh
Feb 4, 2026Feb 6, 2026
Page 1599 of 2052
← PrevNext →
traded Feb 4, 2026
+2d
SEC Form 4

Evidence

17
MC
Martens Robert C.SVP-Chief Innovation & Design
ALLEAllegion plc
Grant or award
A—
3,054 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
PR
Putnam Leah RChief Accounting Officer
BBBYBED BATH & BEYOND, INC.
Option exercise
M$5.81
5,811 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
161.7K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
65.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M$1.89
18.9K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
TS
Trivedi SurekhaSVP, Strategy & Sustainability
VLTOVeralto Corp
Grant or award
A—
537 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

17
SH
Stone John HDirector, President and CEO
ALLEAllegion plc
Grant or award
A—
30.5K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
HL
Hawes Jennifer LSVP - Chief HR Officer
ALLEAllegion plc
Grant or award
A—
2,777 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Tax withholding
F—
6,274 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
SC
Sawyer Dorothy CVP
TROWPRICE T ROWE GROUP INC
Gift
G—
5,155 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

16
MT
McLain William Thomas Jr.EVP, CFO
EMNEASTMAN CHEMICAL CO
Tax withholding
F$207K
2,636 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
MC
Martens Robert C.SVP-Chief Innovation & Design
ALLEAllegion plc
Tax withholding
F$155K
907 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
IS
Ilardi David S.SVP - Allegion Americas
ALLEAllegion plc
Tax withholding
F$208K
1,212 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
LH
Lamb William HDirector
TBBKBancorp, Inc.
Gift
G—
1,200 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
LH
Lamb William HDirector
TBBKBancorp, Inc.
Gift
G—
1,200 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
OJ
Olenik John JVP-Research & Engineering
PLPCPREFORMED LINE PRODUCTS CO
Tax withholding
F$242K
987 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Tax withholding
F$247K
2,470 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
HL
Hawes Jennifer LSVP - Chief HR Officer
ALLEAllegion plc
Tax withholding
F$142K
830 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
MT
McLain William Thomas Jr.EVP, CFO
EMNEASTMAN CHEMICAL CO
Option exercise
M$196K
3,013 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

15
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
346.8K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
OL
Oliver Robin LeighDirector, President, COO
BAFNBayFirst Financial Corp.
Tax withholding
F$891
134 sh
Feb 3, 2026Feb 6, 2026
traded Feb 3, 2026
+3dSEC Form 4

Evidence

15
KW
Kolbeck Roland WilhelmChief Scientific Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
334.9K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
MR
McPherson Danny REVP - Technology & CSO
VRSNVERISIGN INC/CA
Tax withholding
F$388K
1,601 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

15
HL
Hess Janice L.Director
ESEESCO TECHNOLOGIES INC
Option exercise
M$322K
1,349 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

15
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
96.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
HW
Hall Jesse WayneChief Medical Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
343.3K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
KW
Kolbeck Roland WilhelmChief Scientific Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
95.7K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
MJ
McKim Scott JosephEVP, Chief Financial Officer
BAFNBayFirst Financial Corp.
Tax withholding
F$592
89 sh
Feb 3, 2026Feb 6, 2026
traded Feb 3, 2026
+3dSEC Form 4

Evidence

15
AE
Andrews Charles Elliott Jr.Chief Accounting Officer
CGCarlyle Group Inc.
Tax withholding
F$352K
6,354 sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

15
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
99.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
HW
Hall Jesse WayneChief Medical Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
98.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
336.3K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
CM
Conner Penelope MDirector
ESEESCO TECHNOLOGIES INC
Option exercise
M$322K
1,349 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
HJ
Honeycutt JenniferDirector, President and CEO
VLTOVeralto Corp
Grant or award
A—
2,766 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
MA
Musial Nickolas A.VP, Controller & CAO
ALLEAllegion plc
Grant or award
A—
557 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
BS
BP SPAC Sponsor II LLC10% Owner
APACStoneBridge Acquisition II Corp
Grant or award
A—
100.0K sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
OJ
Olenik John JVP-Research & Engineering
PLPCPREFORMED LINE PRODUCTS CO
Grant or award
A—
1,160 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
CL
Claxton Timothy L.Director
SBFGSB FINANCIAL GROUP, INC.
Grant or award
A$25K
1,150 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
PK
Pai KathleenEVP, Chief People Officer
NABLN-able, Inc.
Grant or award
A—
50.8K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence